The chipmaker highlighted ongoing healthcare ambitions, including a partnership with Eli Lilly and an investment in small biotech Generate Biomedicines. The note is largely informational, with no disclosed financial impact or targets.
The chipmaker highlighted ongoing healthcare ambitions, including a partnership with Eli Lilly and an investment in small biotech Generate Biomedicines. The note is largely informational, with no disclosed financial impact or targets.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
neutral
Sentiment Score
0.05
Ticker Sentiment
